Company / FCF Margin
Ligand Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
18.2%
FY2025
5-year range
18.2% / 61.1%
FY2021-FY2025
Trend
-68.0%
vs FY2024
Sector context
#36 of 134
Health Care
What the data says
At 18.2%, Ligand Pharmaceuticals, Inc.'s fcf margin ranks #36 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 10 years, ranging from -26.5% in FY2019 to 295.3% in FY2017.
Based on SEC 10-K filings.
18.2% in FY2025 with a 5-year CAGR of -12.4%.
Declined from 35.1% to 18.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -42.9pp
- 5-Year Change
- -12.4pp
- 10-Year Change
- -
Sector benchmark
#36 of 134 in Health CareTop 27% of 134This company 18.2% Sector average -637.8%
▼
+102.9% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 68.0% year-over-year.
- Currently 656.0pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 18.2% | -68.0% |
| FY2024 | 57.0% | +62.5% |
| FY2023 | 35.1% | -42.6% |
| FY2022 | 61.1% | +110.7% |
| FY2021 | 29.0% | -5.4% |
| FY2020 | 30.6% | +215.6% |
| FY2019 | -26.5% | -134.5% |
| FY2018 | 76.8% | -74.0% |
| FY2017 | 295.3% | +446.5% |
| FY2016 | 54.0% | -6.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026